Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125645401 | 12564540 | 1 | I | 20160217 | 20160718 | 20160718 | EXP | US-CIPLA LTD.-2016US07128 | CIPLA | 0.00 | Y | 0.00000 | 20160718 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125645401 | 12564540 | 1 | PS | WARFARIN SODIUM. | WARFARIN SODIUM | 1 | Oral | 5 MG, ALONG WITH 2 MG | UNKNOWN | 90935 | 5 | MG | TABLET | ||||||
125645401 | 12564540 | 2 | SS | WARFARIN SODIUM. | WARFARIN SODIUM | 1 | Oral | 6.5 MG, UNK | 90935 | 6.5 | MG | TABLET | |||||||
125645401 | 12564540 | 3 | SS | WARFARIN SODIUM. | WARFARIN SODIUM | 1 | Oral | 5 MG, UNK | 90935 | 5 | MG | TABLET | |||||||
125645401 | 12564540 | 4 | C | Metoprolol ER | METOPROLOL SUCCINATE | 1 | Unknown | 50 MG, UNK | U | U | 0 | 50 | MG | ||||||
125645401 | 12564540 | 5 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | UNKNOWN | U | U | 0 | ||||||||
125645401 | 12564540 | 6 | C | Levothyroxin | LEVOTHYROXINE | 1 | Unknown | UNKNOWN | U | U | 0 |
Indications of drugs used
no results found |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125645401 | 12564540 | International normalised ratio fluctuation |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |